| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dddeba5b23dd2faba81ac7a42c52f37 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| filingDate |
2022-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5165759d96bd54550a500c278a7ecdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a18a32f54424f3eefe4c54d7ce5cfae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae8fa4ad772500e292358017c424e189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52cfd417178637d72a115b92dba1d7ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65bdf3e64e9681b985822dc973696b47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04a07982e2219a6912207933a2ecd301 |
| publicationDate |
2022-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114907355-A |
| titleOfInvention |
A kind of dihydropyrimidine compound, its preparation method and application |
| abstract |
The invention discloses a dihydropyrimidine compound, a preparation method and application thereof. Specifically, the present invention discloses a dihydropyrimidine compound represented by formula I' or a pharmaceutically acceptable salt thereof, as well as a composition containing the compound and the use of the compound for the preparation of medicines related to the treatment and prevention of HBV infection . The dihydropyrimidine compounds in the present application can effectively inhibit the activity of HBV (hepatitis B virus) in HepG2.2.15 cells and have little toxicity to liver cancer cells. |
| priorityDate |
2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |